APELLIS PHARMACEUTICALS INC's ticker is and the CUSIP is 03753UAB2. A total of 23 filers reported holding APELLIS PHARMACEUTICALS INC in Q3 2021. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $14,863,606 | -47.3% | 11,766,000 | 0.0% | 0.17% | -50.1% |
| Q2 2023 | $28,207,024 | +24.4% | 11,766,000 | -3.4% | 0.34% | +25.0% |
| Q1 2023 | $22,669,901 | +21.2% | 12,175,000 | 0.0% | 0.27% | +38.1% |
| Q4 2022 | $18,702,513 | +15.0% | 12,175,000 | +46.2% | 0.19% | +10.9% |
| Q3 2022 | $16,256,000 | -75.0% | 8,325,000 | -81.0% | 0.18% | -73.1% |
| Q2 2022 | $65,016,000 | -33.0% | 43,874,000 | -28.5% | 0.65% | -31.3% |
| Q1 2022 | $97,046,000 | +36.9% | 61,374,000 | +30.9% | 0.95% | +43.5% |
| Q4 2021 | $70,903,000 | +69.3% | 46,874,000 | +37.9% | 0.66% | +82.8% |
| Q3 2021 | $41,869,000 | -47.5% | 33,996,000 | -20.7% | 0.36% | -40.5% |
| Q2 2021 | $79,763,000 | +1796.4% | 42,855,000 | +1328.5% | 0.61% | +1586.1% |
| Q1 2021 | $4,206,000 | -80.0% | 3,000,000 | -76.0% | 0.04% | -76.6% |
| Q4 2020 | $20,991,000 | +54.4% | 12,502,000 | 0.0% | 0.15% | +27.3% |
| Q3 2020 | $13,594,000 | – | 12,502,000 | – | 0.12% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 28,825,000 | $35,498,000 | 0.69% |
| DeepCurrents Investment Group LLC | 15,079,000 | $18,525,000 | 0.55% |
| WOLVERINE ASSET MANAGEMENT LLC | 33,996,000 | $41,869,000 | 0.36% |
| Weiss Asset Management LP | 9,000,000 | $10,980,000 | 0.28% |
| SSI INVESTMENT MANAGEMENT LLC | 3,418,000 | $4,192,000 | 0.25% |
| Baker Brothers Advisors | 46,754,000 | $57,262,000 | 0.25% |
| MACKAY SHIELDS LLC | 15,855,000 | $19,641,000 | 0.18% |
| Verition Fund Management LLC | 4,310,000 | $5,350,000 | 0.05% |
| WESTWOOD HOLDINGS GROUP INC | 1,000,000 | $1,236,000 | 0.01% |
| GIRARD PARTNERS LTD. | 66,081 | $162,000 | 0.01% |